MedTrace Logo

Post Market Evaluation of Real World Outcomes and Durability to Support Implantable Inceptiv™ Spinal Cord Stimulation Therapy

NCT07507422 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 970

Last updated 2026-05-04

No results posted yet for this study

Summary

The PERSIST study is being conducted within Medtronic's active post-market surveillance platform, the Product Surveillance Registry (PSR). The purpose of PERSIST is to generate long-term evidence for the Inceptiv™ Spinal Cord Stimulation therapy.

Conditions

Interventions

DEVICE

Commercially available Inceptiv™ neurostimulation systems

Spinal cord stimulation therapy delivered during trialing and following implant of commercially available Inceptiv™ neurostimulation systems

Sponsors & Collaborators

Principal Investigators

  • Holly Norman, PhD, MBA · Medtronic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-17
Primary Completion
2029-06-27
Completion
2034-01-11
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07507422 on ClinicalTrials.gov